Budget law calls for BARDA and FDA to establish “warm base” manufacturing to better prepare for future pandemics
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicySupply Chain Management